The Pharmacy and Poisons Board has approved the use of a prescription drug for the treatment of prostate cancer.
The drug, ZYTIGA (abiraterone acetate), is manufactured by Janssen, one of the pharmaceutical companies of Johnson & Johnson.
The local pharmacy regulator has approved the use of the once-daily medication for the treatment of metastatic castration-resistant prostate cancer ahead of a chemotherapy regime.
“The drug is only licensed for the treatment of advanced prostate cancer cases post-chemotherapy,” Janssen Kenya Country Manager Marseille Onyango said.
Fadlu Davids plans to use an offensive style with Simba SC during their match against Al-Masry of Egypt for the…
Tonight, the Golden State Warriors will play the Phoenix Suns at PHX Arena with Stephen Curry receiving official approval to…
South Africa's very first multiple-party government from the post-apartheid period deals with critical threats as ANC and DA leaders fight…
Police shot and killed a protected witness in South Africa's Wynberg Magistrate's Court in Cape Town on the morning of…
The 2025/26 season marks the start of the new Proteas Men's contracted squad as CSA has given 18 national contracts…
Low-cost European airline companies started flying directly to Western Sahara even though Morocco and Polisario Front keep fighting for its…
This website uses cookies.